Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Patients with chronic heart failure have a higher mortality risk or are more likely to undergo a heart transplant if they have low…
NEW YORK (Reuters Health) – During the first year of treatment for chronic hepatitis B, tenofovir and entecavir are the most effective antiviral agents available, according to the…
NEW YORK (Reuters Health) –There’s no reliable evidence to support or refute the use of glucocorticoids for treating anaphylaxis, despite recommendations found in several guidelines, according to the…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who have fairly high cholesterol levels despite simvastatin treatment do better with the addition of ezetimibe, Italian investigators…
NEW YORK (Reuters Health) – Patients infected with hepatitis C virus (HCV) type 1 who have a slow response to pegylated interferon-alfa and ribavirin can benefit from continuing…
NEW YORK (Reuters Health) – The dose of misoprostol given after mifepristone for termination of early pregnancy should stay at the recommended dose rather than be lowered, a…
NEW YORK (Reuters Health) – HIV-positive patients taking efavirenz are at risk for clinically significant vitamin D deficiency, and for excessive bone turnover if they are taking tenofovir,…
NEW YORK (Reuters Health) – Episodes of dyspnea are more common in patients treated with the antiplatelet agent than in those taking clopidogrel, although the clinical importance of…
NEW YORK (Reuters Health) – Cumulative exposure to particular antiretroviral agents in patients being treated for HIV infection is associated with an increased risk of developing chronic kidney…
NEW YORK (Reuters Health) – Among patients with metabolic syndrome and mixed dyslipidemia, treatment with fenofibric acid in combination with a statin reduces the prevalence of metabolic syndrome…
